Apposite Capital‑backed Kelso Pharma Acquires Stirling Anglian Pharmaceuticals

Kester Capital Acquires EMAS Pharma (carve-out from Bionical Emas)

December 24, 2024

Healthcare Services

Kester Capital has acquired EMAS Pharma, the clinical development division of Bionical Emas, in a carve-out transaction alongside an incoming executive team led by experienced CRO operators. The deal creates an independent CRO platform that Kester and the management team intend to scale organically and through acquisitions, expanding capabilities and geographic presence in North America and Europe.

Novastone Capital Advisors Acquires Keystone Specialty Pharmacy

July 16, 2024

Healthcare Services

Novastone Capital Advisors (NCA), a Switzerland-based private equity firm, has acquired Keystone Specialty Pharmacy, a specialty pharmacy based in Mississippi. The acquisition was completed as part of NCA’s Entrepreneurship through Acquisition (ETA) program; Dr. Lisa Piercey will lead the pharmacy and the sellers were owners Jeffrey and Kim Clark.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

Sterling Pharma Solutions Acquires Novartis Ringaskiddy API Manufacturing Facility

January 11, 2023

Pharmaceuticals

Sterling Pharma Solutions, a GHO Capital portfolio company, has completed the acquisition of the Novartis API manufacturing facility in Ringaskiddy, County Cork, Ireland. The 111-acre site (with ~350 transferred employees and extensive commercial-scale API production capacity) expands Sterling's European manufacturing footprint and includes an ongoing supply agreement with Novartis.

Stirling Square Capital Acquires Sustainable Agro Solutions (SAS)

July 8, 2021

Agriculture

Stirling Square Capital has acquired Sustainable Agro Solutions (SAS), a Lleida-headquartered developer and producer of biostimulants, soil and water improvers, and specialty plant nutrition solutions. The acquisition is a platform investment for Stirling Square aimed at supporting SAS’s international growth, sustainability initiatives and consolidation in the fragmented biostimulants market.

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.